Holen Sie sich die Stockscreener-App
1.19
6.69%
-0.08
Schlusskurs vom Vortag:
$1.27
Offen:
$1.24
24-Stunden-Volumen:
159.36K
Relative Volume:
0.33
Marktkapitalisierung:
$30.83M
Einnahmen:
$2.83M
Nettoeinkommen (Verlust:
$-7.95M
KGV:
-0.4424
EPS:
-2.6898
Netto-Cashflow:
$-7.01M
1W Leistung:
-14.75%
1M Leistung:
-54.77%
6M Leistung:
-90.85%
1J Leistung:
-63.06%
1-Tages-Spanne:
$1.14
$1.28
1-Wochen-Bereich:
$1.11
$1.38
52-Wochen-Spanne:
$1.11
$99.75
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
Firmenname
Novabay Pharmaceuticals Inc
Sektor
Branche
Telefon
510-899-8800
Adresse
2000 Powell Street, Suite 1150, Emeryville, CA
Compare NBY vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
1.18 | 33.18M | 2.83M | -7.95M | -7.01M | -2.6898 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.36 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.68 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
702.39 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.56 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.18 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-09-18 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-07-06 | Bestätigt | H.C. Wainwright | Buy |
| 2017-11-15 | Bestätigt | Laidlaw | Buy |
| 2017-06-05 | Eingeleitet | ROTH Capital | Buy |
| 2017-03-27 | Eingeleitet | Laidlaw | Buy |
| 2017-02-06 | Eingeleitet | Rodman & Renshaw | Buy |
| 2016-03-07 | Herabstufung | Maxim Group | Buy → Hold |
| 2015-12-14 | Bestätigt | Maxim Group | Buy |
| 2015-04-30 | Fortgesetzt | Maxim Group | Buy |
| 2013-03-06 | Eingeleitet | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | Eingeleitet | Dawson James | Speculative Buy |
Alle ansehen
Novabay Pharmaceuticals Inc Aktie (NBY) Neueste Nachrichten
NovaBay Pharmaceuticals Approves Issuance of 837 Million Shares and 2026 Equity Incentive Plan in Shareholder Vote - Minichart
NovaBay Pharmaceuticals shareholders approve charter amendments and stock issuance - Investing.com
NovaBay Pharma Expands Share Capital and Governance Flexibility - TipRanks
Novabay Pharmaceuticals: All six proposals, including share issuances and governance amendments, were approved - TradingView
Novabay Pharmaceuticals: All six proposals, including share issuances and governance changes, were approved - TradingView
Dividend Watch: Will NovaBay Pharmaceuticals Inc stock hit new highs in YEARPortfolio Update Report & Stock Market Timing Techniques - baoquankhu1.vn
Aug Decliners: Will NovaBay Pharmaceuticals Inc stock hit new highs in YEARTrade Entry Report & Daily Volume Surge Trade Alerts - baoquankhu1.vn
NBY Earnings History & Surprises | EPS & Revenue Results | NOVABAY PHARMACEUTICALS INC (NYSEARCA:NBY) - ChartMill
Breakouts Watch: What are the risks of holding NovaBay Pharmaceuticals IncPortfolio Growth Summary & Weekly Market Pulse Updates - baoquankhu1.vn
Gross margin % of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
NBY SEC FilingsNovabay Pharma 10-K, 10-Q, 8-K Forms - Stock Titan
Net current asset value per share of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
NovaBay Pharmaceuticals, Inc. Earnings and Revenue – GETTEX:B9P1 - TradingView
Cash per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Price Passes Below 50-Day Moving AverageHere's What Happened - MarketBeat
Diluted net income available to common stockholders of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Debt to assets ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Tangible book value per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Net current asset value per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Enterprise value to EBITDA ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Free cash flow per share of NovaBay Pharmaceuticals, Inc. – FWB:B9P1 - TradingView
Operating income of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Price to cash flow ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Diluted shares outstanding of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Total revenue of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Free cash flow of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Enterprise value of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Operating expenses (excl. COGS) of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Number of employees of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Gross margin % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Operating margin % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Return on invested capital % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Diluted earnings per share (diluted EPS) of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
EBITDA of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Free cash flow per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
EBITDA per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Total liabilities of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Debt to equity ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Cash from operating activities of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Long term debt to total equity ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
NovaBay Pharmaceuticals, Inc. Earnings and Revenue – MUN:B9P1 - TradingView
EBIT of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Operating income of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Average basic shares outstanding of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Total operating expenses of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Net debt of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Total liabilities & shareholders' equities of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Cost of goods sold of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Total equity of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Quick ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
NovaBay Pharmaceuticals, Inc. Cash Flow – MUN:B9P1 - TradingView
Finanzdaten der Novabay Pharmaceuticals Inc-Aktie (NBY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.18%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):